MitoPharm Corporation Announces That Patented Use of This Newly Discovered Compound, (-) Schisandrin B, for the Prevention and Treatment of Ischemic Heart Disease Has Been Applied for With the US Patent and Trademark Office

SEATTLE--(BUSINESS WIRE)--Mitopharm Corporation, Inc. (Pink Sheets:MTPM), releases the results of a research paper where Professor Dr. Robert Ko reports on (-) Schisandrin B – a new compound discovered by Dr. Ko – as a more potent agent in protecting the heart against Myocardial Ischemia-Reperfusion than its precursor, Schisandrin B. www.mitopharm.com